Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296272 | 12629627 | 2 | F | 20160711 | 20160809 | 20160808 | 20160816 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN103541 | GLAXOSMITHKLINE | 81.00 | YR | F | Y | 0.00000 | 20160816 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296272 | 12629627 | 1 | PS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 8 MG, QD | 22008 | 8 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 126296272 | 12629627 | 2 | C | DOPACOL | CARBIDOPALEVODOPA | 1 | 0 | ||||||||||||
| 126296272 | 12629627 | 3 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 126296272 | 12629627 | 4 | C | COMTAN | ENTACAPONE | 1 | 0 | ||||||||||||
| 126296272 | 12629627 | 5 | C | SENNOSIDE | SENNOSIDES | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126296272 | 12629627 | 1 | Parkinson's disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126296272 | 12629627 | Dyspnoea | |
| 126296272 | 12629627 | Suffocation feeling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |